[FULC] QoQ Quarter Result on 30-Jun-2022 [#Q1]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q1]
Profit Trend
QoQ- -31.76%
YoY- -73.40%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 295 685 1,183 1,882 2,592 5,058 4,935 -84.73%
PBT -24,779 -26,135 -23,738 -34,070 -25,928 -23,484 -20,716 12.69%
Tax -3,161 -2,505 313 -24 -70 -621 19 -
NP -21,618 -23,630 -24,051 -34,070 -25,858 -23,484 -20,716 2.88%
Tax Rate - - - - - - - -
Total Cost 21,913 24,315 25,234 35,952 28,450 28,542 25,651 -9.97%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -7,328.14 -3,449.64 -2,033.05 -1,810.31 -997.61 -464.29 -419.78 574.12%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.36 -0.45 -0.52 -0.83 -0.64 -0.58 -0.57 -26.40%
EPS Diluted -0.36 -0.45 -0.52 -0.83 -0.64 -0.58 -0.57 -26.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.